Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 20, 2016 16:05 ET | Source: Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data at ASM Microbe 2016

WATERTOWN, Mass., June 20, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
June 15, 2016 08:00 ET | Source: Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals to Present at 2016 JMP Securities Life Sciences Conference

WATERTOWN, Mass., June 15, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
May 23, 2016 08:30 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Announces Presentation of Data at ASM Microbe 2016

WATERTOWN, Mass., May 23, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced seventeen data presentations at the American Society of Microbiology (ASM) Microbe...
May 12, 2016 16:05 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Provides Update on Eravacycline Regulatory and Development Status

– Additional phase 3 clinical trial in cIAI planned to support NDA filing – –Phase 3 clinical trial in cUTI planned for future supplemental NDA – – Company to host conference call at 4:30 p.m. ET...
May 04, 2016 16:30 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Reports First Quarter 2016 Financial Results

WATERTOWN, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
April 07, 2016 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Present Data at 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

WATERTOWN, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced five data presentations at the 26th European Congress of Clinical Microbiology...
April 06, 2016 08:00 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Present at Needham Conference 2016

WATERTOWN, Mass., April 06, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
March 10, 2016 09:10 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Present at Roth Conference 2016

WATERTOWN, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
February 23, 2016 16:01 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Reports Fourth-Quarter and Full-Year 2015 Financial Results and Provides Corporate Update

WATERTOWN, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
February 19, 2016 09:14 ET | Source: Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals to Host Conference Call on February 23 to Discuss Fourth Quarter and Full Year Financial Results and Provide Corporate Update

WATERTOWN, Mass., Feb. 19, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...